Articles by tag: Cost Plus Drugs

Mayo Clinic Doctor Says Mark Cuban’s Cost Plus Drugs is Bringing “Access” to U.S. Healthcare

Cost Plus Drugs Mayo Clinic
  Mark Cuban's Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of Read more

Latest

Influence and Connection across Healthcare starts with a VOICE
September 29, 2023

In the latest episode of the Healthcare Rethink podcast, presented by FinThrive, host Brian Urban sits down with Alex Maiersperger, the Global Principal Healthcare at SAS. Their conversation charts the role voice plays in influencing and connecting the healthcare industry. Maiersperger, who co-founded the Advancement League, shares his journey from being a healthcare optimist to […]

Read More
Robotic Technology and It’s Impact on Painting Proves That Automation is in The Future
September 29, 2023

The advent of robotic technology is revolutionizing manufacturing and painting processes by elevating them to unprecedented heights. Tony Kerkhove, a seasoned professional in the painting industry, has a firsthand account of the transformative impact of robots within DeGeest Corporation’s paint department, where automation is integrated to streamline workloads and increase efficiency. The robots replicate […]

Read More
Technetics Groups’ Sealing Solutions are Propelling Company’s Expansion
September 29, 2023

The market for sealing solutions is a demanding one, but Technetics Group emerges as a global leader, with over a century of invaluable experience making it a trusted partner in the industry. Their unique solutions, grounded in extensive knowledge and innovative practices, push the boundaries in discovering improved results. The company also harnesses science […]

Read More
All Articles
Mayo Clinic Doctor Says Mark Cuban’s Cost Plus Drugs is Bringing “Access” to U.S. Healthcare
November 11, 2022

Mark Cuban’s Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of the prescription price that Big Pharma puts on the marketplace. The big question now is whether the supply chain can fundamentally shift toward Cuban’s low-cost […]

Read More